Although Betulin is often used to treat diabetes and atherosclerosis, the ability of this drug to decrease cholesterol levels and the fact that betulinic acid has been found to prevent Alzheimer’s-induced neurodegenerative issues offer the potential of this SREBP2 inhibitor to benefit Alzheimer’s patients [70]. This evidence concerns the gene SREBF2 and atherosclerosis.